simultaneously , the availability of gamma interferon ( gamma-if ) and interleukin-2 ( il-2 ) may allow for the selective correction of these t-cell deficits , leading to restoration of the patient 's immune responses and perhaps correction of the clinical syndromes .
C0021756
interleukin-2
C0301872
immune responses